Company data
Twist Bioscience Corporation employees and revenue per employee
TWST · Biotechnology · $7.04B market cap
Twist Bioscience Corporation had 979 employees at the end of fiscal Sep 2025, up 6.1% from a year earlier. Revenue for the year was $377M, up 20.3% from a year earlier, or $385K per employee. Revenue and headcount both grew, and revenue grew faster.
Employees
979
+6.1% YoY
Revenue
$377M
+20.3% YoY
Revenue / employee
$385K
Peer median $457K
Rank in industry
65 of 110
Biotechnology
Open roles
55
56 per 1,000 staff
Headcount against revenue
Both lines start at 100 in the first year we hold, so you can see which one grew faster.
Hover a year for the numbers.
| Year ending | Employees | Revenue | Per employee | Staff YoY | Revenue YoY |
|---|---|---|---|---|---|
| Sep 2025 | 979 | $377M | $385K | +6.1% | +20.3% |
| Sep 2024 | 923 | $313M | $339K | +329.3% | +27.7% |
| Sep 2023 | 215 | $245M | $1.14M | -78.3% | +20.4% |
| Sep 2022 | 989 | $204M | $206K | +51.7% | +53.8% |
| Sep 2021 | 652 | $132M | $203K | +24.2% | +46.9% |
| Sep 2020 | 525 | $90.1M | $172K | +26.8% | +65.7% |
| Sep 2019 | 414 | $54.4M | $131K | +508.8% | +113.9% |
| Sep 2018 | 68 | $25.4M | $374K | — | — |
Open roles on its job board: 55 (56 per 1,000 staff, against its latest annual headcount), as of 2026-11-20. Tracked since 2026-10-03. No 90 day change yet.
Twist Bioscience Corporation against similar companies
The closest industry peers by revenue, from Biotechnology.
| Company | Employees | Revenue | Revenue / employee | Shape |
|---|---|---|---|---|
| INVA Innoviva, Inc. | 159 | $425M | $2.67M | Hiring ahead |
| RIGL Rigel Pharmaceuticals, Inc. | 172 | $294M | $1.71M | Efficient growth |
| CRMD CorMedix Inc. | 191 | $312M | $1.63M | Efficient growth |
| KRYS Krystal Biotech, Inc. | 295 | $389M | $1.32M | Efficient growth |
| TARS Tarsus Pharmaceuticals, Inc. | 370 | $451M | $1.22M | Efficient growth |
| ARQT Arcutis Biotherapeutics, Inc. | 354 | $376M | $1.06M | Efficient growth |
| TVTX Travere Therapeutics, Inc. | 497 | $491M | $987K | Efficient growth |
| XERS Xeris Biopharma Holdings, Inc. | 435 | $292M | $671K | Efficient growth |
| TWST Twist Bioscience Corporation | 979 | $377M | $385K | Efficient growth |
Questions about Twist Bioscience Corporation
- How many employees does Twist Bioscience Corporation have?
- Twist Bioscience Corporation reported 979 employees for the fiscal year ending Sep 2025, in the annual report it filed on November 17, 2025. That is up 6.1% from a year earlier.
- What is Twist Bioscience Corporation's revenue per employee?
- Twist Bioscience Corporation brought in $377M of revenue in fiscal Sep 2025, which is $385K per employee. That ranks 65 of 110 companies we track in Biotechnology, where the median is $457K.
- Is Twist Bioscience Corporation hiring?
- Twist Bioscience Corporation's public job board listed 55 open roles on November 20, 2026, about 56 per 1,000 staff.
- Where do these numbers come from?
- Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.
Outpick research
This page is the filings. The research is a membership.
On the first and third Friday of each month Outpick publishes one stock pick with the full case for owning it, adds it to a live portfolio you can audit, and writes a note when a position closes. A new account gets 21 days of the whole membership with no card, and nothing is charged when it ends.
Free game
Think you can pick better than the S&P 500?
Pick 15 stocks, lock them in, and we score them against the index every trading day for ten years. Free, with a public leaderboard.
Enter the challengeMore data
Compare TWST with the rest of the market
See who earns the most per employee, who is hiring, and who is cutting, across every company we track.
Source: employee counts and revenue as stated in Twist Bioscience Corporation's annual reports (Form 10-K), latest filed November 17, 2025. This is data, not a recommendation to buy or sell TWST.